logo
A new COVID variant is spreading in the US: What are the symptoms?

A new COVID variant is spreading in the US: What are the symptoms?

Yahoo23-06-2025
A new COVID-19 variant that was unheard of just months ago is now projected to be the second-most common strain in the U.S.
Variant NB.1.8.1 was first detected in China in January but accounted for about 0% of cases in the U.S. until May. By early June, it was estimated to account for up to 37%, according to the U.S. Centers for Disease Control (CDC).
The World Health Organization (WHO) evaluated the additional public health risk posed by the variant as "low at the global level in a May report, in which it also advised that currently approved COVID-19 vaccines are "expected to remain effective to this variant against symptomatic and severe disease."
Here's what we know about NB.1.8.1.
'Razor blade throat': What to know about COVID-19 variant NB.1.8.1
NB.1.8.1 is one of the latest variants of COVID-19, a "slightly upgraded version" of the LP.8.1 variant that is prominent right now, Subhash Verma, microbiology and immunology professor at the University of Nevada, Reno, previously told USA TODAY in May.
The new variant was first detected in January in China. As of mid-May, the variant had reached 10.7% of global reported COVID-19 cases, according to the World Health Organization (WHO).
Verma previously said NB.1.8.1 may be able to be transferred more easily than LP.8.1. Additionally, he said that NB.1.8.1 is able to evade antibodies created by vaccines or past infections more easily than LP.8.1.
"NB.1.8.1 is likely to spread more rapidly and evade our immune defenses more easily than LP.8.1, which is why this variant requires careful monitoring," Verma said.
For a two-week period starting on May 25 and ending on June 7, the CDC's Nowcast estimates tracker shows projections for the different COVID-19 variants. According to the latest CDC data, the NB.1.8.1 strain is projected to be the second highest in the U.S., making up 37% of the total cases recorded in the U.S.
The most common strain is LP.8.1, also known as Omicron, which accounts for 38% of cases, followed by NB.1.8.1 with 37%, XFG with 8%, XFC making up 7%, and LF.7.9 with 4%.
The prominence of NB.1.8.1 in the U.S. has significantly increased in recent weeks, accounting for 0% of cases through March before reaching 2% in April, 5% in early May and 15% by late May.
The CDC has not outlined symptoms that are specific to the NB.1.8.1. variant. Verma said that NB.1.8.1 symptoms appear similar to those of earlier COVID-19 variants.
However, an extremely sore throat, colloquially called "razor blade throat," has been associated with the new variant.
People with the variant have reported a feeling akin to their throats being covered with razor blades, according to the Los Angeles Times, Fox News, SF Gate, and other news outlets. Many people have also taken to social media to describe the "razor blade throat."
The CDC outlines the following as common COVID-19 symptoms:
Fever or chills
Cough
Shortness of breath or difficulty breathing
Sore throat
Congestion or a runny nose
New loss of taste or smell
Fatigue
Muscle or body aches
Headache
Nausea or vomiting
The CDC advises seeking medical care if you experience any of the following symptoms:
Trouble breathing
Persistent pain or pressure in the chest
New confusion
Inability to wake or stay awake
Depending on skin tone, lips, nail beds and skin may appear pale, gray or blue
The World Health Organization states that currently approved COVID-19 vaccines are expected to remain effective against the NB.1.8.1 variant.
In a webpage dated Jan. 7, 2025, the CDC advises that everyone over the age of six months get the 2024-2025 COVID-19 vaccine, specifically the 2024-2025 Moderna COVID-19 Vaccine.
It also suggests that people who have never received a COVID-19 vaccine, are age 65 and older, are immunocompromised, live at a long-term care facility, are pregnant, breastfeeding, trying to get pregnant, and/or want to avoid getting long COVID, should get the vaccine, especially.
However, Health and Human Services Secretary Robert F. Kennedy Jr. said on May 27 that the COVID-19 vaccine would no longer be included in the CDC's recommended immunization schedule for healthy children and pregnant women, a move that broke with previous expert guidance and bypassed the normal scientific review process.
Under the changes, the only people who will be recommended for COVID-19 vaccines are those over 65 and people with existing health problems. This could make it harder for others who want the COVID-19 vaccine to get it, including health care workers and healthy people under 65 with a vulnerable family member or those who want to reduce their short-term risk of infection.
This could mean that some who still wish to receive the vaccine may have to pay out of pocket, if they are able to access it at all. It is not yet known how accessible the COVID-19 vaccine will be moving forward.
Increasing Community Access to Testing, Treatment and Response (ICATT), a federal program, continues to provide free COVID-19 testing to individuals without health insurance.
According to the CDC, as of May 27, more than 19,000 locations across the country offer free testing. To find a location near you that offers free testing, visit testinglocator.cdc.gov/Search.
This article originally appeared on USA TODAY: New COVID variant spreading in US: 2025 symptoms, what to know
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

What's the Connection Between Statins and Dementia?
What's the Connection Between Statins and Dementia?

Health Line

time13 minutes ago

  • Health Line

What's the Connection Between Statins and Dementia?

There are conflicting research findings as to whether the use of statins can protect from dementia or increase the risk of dementia. While some older research has pointed to the possibility of a correlation, more recent studies showed that this drug class may lower your risk for dementia, including Alzheimer's disease. Statins are a type of medication taken to lower cholesterol levels in the blood. They prevent an enzyme called hydroxymethylglutaryl-CoA reductase (HMG-CoA reductase), which is involved in the production of cholesterol in the liver. Benefits of statins Benefits include lowering LDL ('bad') cholesterol levels, reducing the risk of heart disease, and preventing plaque buildup in your arteries. These medications include atorvastatin (Lipitor) and rosuvastatin (Crestor), among others. In 2012, the Food and Drug Administration issued a warning that statin use could rarely cause memory loss or confusion. The FDA later updated the findings that this cognitive decline was not significant. A growing body of research suggests statins may have a protective effect against dementia. A review of 31 studies published in 2018 supports the idea that statins can help prevent the risk of dementia. The researchers found that taking statins for 1 year decreased dementia risk by about 20%, while an average daily 5-milligram (mg) dose was associated with an 11% decrease in dementia risk. The researchers noted that because high cholesterol is a risk factor for dementia, lowering it could have positive effects on the brain. According to a 2020 review, statins may help short- and long-term delay of dementia progression in people over 65 years old with the condition, although the researchers noted that their findings were insufficient to make a definitive statement. Studies in 2021 and 2023 also pointed in the direction of statins having a protective effect against dementia, though the results were not conclusive. Research discrepancies Researchers in a 2022 study pointed out that discrepancies among studies is possibly related to smaller sample sizes and biases in the research methods, as well as wide ranges in the ages of participants, and co-existing conditions. Additionally, these researchers pointed out that different types of statins have different cognitive effects. Most scientists and medical professionals agree that more research is needed on the cognitive effects of statins, and there are studies in progress. If you have high cholesterol, it's important to get advice from a medical professional. High cholesterol is a risk factor for diseases that can affect your independence and life span, such as: heart disease dementia stroke heart attack While some people can experience improvement with lifestyle modifications, many who have high cholesterol need to take cholesterol-lowering medication. You and your doctor can discuss a plan that's individualized for you.

Aurora Borealis May Hit These 16 States Over the Next Two Days
Aurora Borealis May Hit These 16 States Over the Next Two Days

CNET

time26 minutes ago

  • CNET

Aurora Borealis May Hit These 16 States Over the Next Two Days

Alongside fireworks and drone shows, people in select parts of the US will have another excuse to look up at the sky this week. The sun has graced Earth with another round of solar material, which will interact with our atmosphere and make sections of the sky glow. Of course, we're talking about the aurora borealis, and it'll be visible in 16 states on Tuesday and Wednesday night. Of the two days, Tuesday night into Wednesday morning will be your best shot. The Space Weather Prediction Center is forecasting a Kp 5 magnetic storm that's scheduled to hit over six hours starting late Monday evening. The K-Index measures the horizontal impact of geomagnetic storms, and a Kp 5 rating results in what NOAA calls a "moderate" aurora. Things will calm down a bit Wednesday night going into Thursday morning, with the aurora pulling back a bit and being less visible unless you're on the northern border with Canada. NOAA is forecasting a Kp 4 magnetic storm that night. NOAA predicts the northern lights reaching into the US on Tuesday and Wednesday. NOAA Which states could see the aurora borealis? Per the Space Weather Prediction Center, Tuesday night's aurora will be visible in Washington state, Idaho, Montana, Wyoming, North and South Dakota, Minnesota, Iowa, Wisconsin, Michigan, and the northernmost sections of New York, Vermont, New Hampshire, and most of Maine. Alaska and Canada will have the best views by a wide margin, with the entire state of Alaska getting coverage. Technically, there will also be a slice of Oregon, putting the full number at 16, but unless you live on the northeastern tip, you likely won't see anything. Much like Earth's weather, space weather prediction can be hit or miss. So, if you're in any of the above states, it's worth taking a look if you're up that late. It may be slightly stronger or weaker than forecasted, which will affect how far south the northern lights reach. It won't be as strong as the epic show we saw in May 2024. Tips on viewing the northern lights The standard space viewing tips all apply here. You'll get a better view if you get away from the city and suburbs to avoid light pollution. Weather will play a role as well, since clouds will obfuscate the view. If you attempt to photograph the aurora, we recommend using long exposure times to give your camera more time to soak in the light. Other than that, you'll want to look toward the northern horizon to give yourself the best chance at a good view since that's where the northern lights originate.

Man's body crawling with parasitic worms after infected kidney transplant at US hospital
Man's body crawling with parasitic worms after infected kidney transplant at US hospital

Yahoo

time26 minutes ago

  • Yahoo

Man's body crawling with parasitic worms after infected kidney transplant at US hospital

When you buy through links on our articles, Future and its syndication partners may earn a commission. Two men were left riddled with parasitic worms after they received infected kidney transplants at two U.S. hospitals, a new case report reveals. The two kidneys had come from the same organ donor, who had resided in the Caribbean before death, according to the report, published June 18 in the New England Journal of Medicine. The first of the two kidney recipients, a 61-year-old man, had undergone transplant surgery at Massachusetts General Hospital (MassGen). Ten weeks after receiving the transplant, he was transferred back to MassGen after an initial admission to a different hospital. He had developed nausea, vomiting, excessive thirst, abdominal discomfort, back pain and a fever. At the first hospital, doctors found fluid building up in his lungs, and the man began breathing quickly, feeling as though he couldn't get enough air, and his oxygen levels dropped. As he entered respiratory failure and shock — meaning he had dangerously low blood pressure — he was transferred to the intensive care unit of MassGen, where doctors documented a purple rash, like a constellation of bruises, spreading across the skin of his stomach. The doctors began an extensive investigation into the patient's medical history and ran a battery of tests to pinpoint the cause of his symptoms. Related: 32 scary parasitic diseases The patient was on immunosuppressive medications to prevent his body from rejecting his new kidney, making him more susceptible to infections. The medical team, including infectious disease and organ transplant expert Dr. Camille Kotton, had the challenge of whittling down a lengthy list of possible infections to find the most likely cause. They could rule out bacterial infections, because the man had been given antibiotics and wasn't improving. He was also taking an antiviral and had tested negative for SARS-CoV-2, the virus behind COVID-19. That left some kind of parasite as a likely culprit. This was backed up by the fact that levels of eosinophils, a type of white blood cell that fights parasitic infections, had also spiked in the man's blood. These cells can also spike due to drug reactions or transplant rejection, but those causes were unlikely given the man's symptoms, Kotton noted. Kotton had heard of cases in which transplanted organs infected their recipients with a small roundworm called Strongyloides stercoralis. She contacted New England Donor Services, a regional organ-procurement organization, about the potential contamination. Although the kidney donor was deceased, they were able to test a vial of the donor's blood, which had antibodies for Strongyloides, meaning the donor's immune system had at some point encountered the worm. Tests of the patient's blood samples showed that he did not have antibodies to Strongyloides before the transplant, but he did afterward. When the medical team sampled various sites across the man's body, they found that the worms had spread far and wide, invading his abdomen, lungs and skin. Infections from transplants are rare — in over 10 years of transplants in the U.S., donor-derived infections affected only 14 out of every 10,000 organ transplants, a review found. U.S. doctors cannot use organs from people with certain active infections, such as tuberculosis, and donated organs are tested for infectious diseases, but these tests don't always catch everything. The review noted 13 proven or probable Strongyloides infections over a decade, accounting for 42% of all parasitic infections transmitted by organ transplants. Prior to this review, fewer than 1 in 4 organ transplant organizations regularly screened for Strongyloides, but in 2023, the Organ Procurement and Transplantation Network called for universal testing for this parasite. The MassGen medical team treated the man with ivermectin, a powerful antiparasitic drug. They received special permission to administer the drug directly underneath his skin to combat the full body infection, which ultimately cured him. RELATED STORIES —A man who couldn't pee had been infected by one of the largest known human parasites —Parasite lurking in woman's brain caused mysterious 'burning' leg sensation —Parasite that lived in woman's eye for 2 years likely came from crocodile meat Meanwhile, other medical centers that had transplanted organs from the same deceased donor were notified. This flagged a 66-year-old man who was being treated at Albany Medical Center for fatigue, low white blood cells and worsening kidney function following a transplant operation. Sharing notes with the MassGen team, the doctors were able to successfully treat this second patient, who had received the donor's other kidney. "Organ transplants save lives," a spokesperson for Albany Medical Center told Live Science in an email. "In rare cases like this, the communication and coordination between our hospitals and the involvement of infectious disease physicians at both hospitals was critically important, as was the alert our regional organ procurement organization provided us." Live Science have contacted MassGen for comment.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store